PIN1 and cancer: Compared with untreated mice, tumor tissues from mice receiving 164B8 displayed significantly reduced Pin1 expression, with a reduction of approximately 30%–50%— consistent with the results of the cell-based assay reported in Figure 3, which examined the time-dependent effect of 164B8 on Pin1 degradation in cancer cells.